Predicting hyperprogressive disease in patients with advanced hepatocellular carcinoma treated with anti-programmed cell death 1 therapy.
Zhang L, Wu L, Chen Q, Zhang B, Liu J, Liu S, Mo X, Li M, Chen Z, Chen L, You J, Jin Z, Chen X, Zhou Z, Zhang S.
Zhang L, et al. Among authors: zhang b, zhang s.
EClinicalMedicine. 2020 Dec 13;31:100673. doi: 10.1016/j.eclinm.2020.100673. eCollection 2021 Jan.
EClinicalMedicine. 2020.
PMID: 33554079
Free PMC article.